Research

Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol

Hajira Dambha-Miller, Ali Albasri, Sam Hodgson, Christopher Wilcox, Nazrul Islam, Shareen Khan, Paul Little and Simon Griffin
BJGP Open 2020; 4 (3): bjgpopen20X101115. DOI: https://doi.org/10.3399/bjgpopen20X101115
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

BJGP Open
Vol. 4, Issue 3
August 2020
Download PDF
Article Alerts
Email Article
Citation Tools
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
Hajira Dambha-Miller, Ali Albasri, Sam Hodgson, Christopher Wilcox, Nazrul Islam, Shareen Khan, Paul Little, Simon Griffin
BJGP Open 2020; 4 (3): bjgpopen20X101115. DOI: 10.3399/bjgpopen20X101115
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords

Advertisement

 
 

British Journal of General Practice